Skip to main content

Table 1 Demographic and clinical characteristics of the studied patients

From: Glioma grading using an optimized T1-weighted dynamic contrast-enhanced magnetic resonance imaging paradigm

Patient no

Sex

Age

Tumor type

1

M

27

Oligodendroglioma (II)

2

F

41

Oligoastrocytoma (II)

3

M

24

Oligodendroglial (III)

4

M

43

Oligodendroglioma (II)

5

M

23

Astrocytoma (II)

6

F

38

Astrocytoma (II)

7

M

50

Anaplastic Oligodendroglioma (III)

8

M

25

Diffuse Astrocytoma (III)

9

M

29

Fibrillary astrocytoma with areas of anaplastic transformation according to WHO(II-III)-(III)

10

F

35

Oligodendroglial(III)

11

M

46

GBM (IV)

12

M

36

Anaplastic Oligodendroglioma (III)

13

F

31

Oligoastrocytoma (II)

14

M

27

Diffuse astrocytoma (II)

15

M

29

Low grade glioma -astrocytoma (II)

16

M

66

Astrocytoma Anaplastic(III)

17

M

35

Oligodendroglioma (II)

18

M

28

Oligoastrocytoma (II)

19

M

41

Gemistocytic astrocytoma with anaplastic transformation (III)

20

F

28

Oligodendroglioma (II)

21

F

38

GBM(IV)

22

M

24

Oligodendroglioma (II)

23

M

56

Oligoastrocytoma (II)

24

M

35

Oligodendroglioma with microcystic component (II)

25

F

39

Oligodendroglioma (III)

26

F

30

Anaplastic astrocytoma (III)

27

M

28

Oligoastrocytoma (II)

28

F

57

GBM (IV)

29

F

36

Oligoastrocytoma (II)

30

F

35

GBM(IV)

31

F

21

GBM(IV)

32

F

78

GBM(IV)

33

M

67

GBM(IV)

34

F

45

GBM(IV)

35

F

49

GBM(IV)